Hong Kong Auto Stock News

While it’s been a great week for Luyuan Group Holding (Cayman) Limited ( HKG:2451 ) shareholders after stock gained...

Looking at Mei Ah Entertainment Group Limited's ( HKG:391 ) insider transactions over the last year, we can see that...

Why Migao Group Holdings’ Latest Earnings Matter For Investors Migao Group Holdings (SEHK:9879) recently released full year results to March 31, 2026, reporting sales of CNY 6,175.32 million and net income of CNY 373.5 million, compared with the prior year’s reported figures. Basic and diluted earnings per share from continuing operations were both CNY 0.41, compared with CNY 0.34 a year earlier. These results give investors a fresh set of numbers to reassess the fertilizer producer’s...

As you might know, Luk Fook Holdings (International) Limited ( HKG:590 ) just kicked off its latest yearly results with...

As global markets navigate mixed performances, with technology shares facing renewed pressure, the Asian market presents intriguing opportunities for investors seeking value. In this environment of shifting valuations and economic adjustments, identifying stocks trading below their intrinsic worth can be a strategic approach to harnessing potential growth while managing risk.

Hypebeast Limited's ( HKG:150 ) solid earnings announcement recently didn't do much to the stock price. We did some...

As global markets face mixed signals, with inflationary pressures and technology stock fluctuations taking center stage, investors are increasingly seeking opportunities in diverse regions. Penny stocks, although an older term, remain relevant as they often represent smaller or newer companies that may offer growth potential at lower price points. By focusing on those with strong financial health and solid fundamentals, investors can uncover hidden gems within the Asian market landscape.

The analysts might have been a bit too bullish on China Gas Holdings Limited ( HKG:384 ), given that the company fell...

CARsgen Therapeutics Holdings (SEHK:2171) has drawn fresh investor attention after China’s National Medical Products Administration approved satricabtagene autoleucel, the first CAR T-cell therapy cleared globally for a solid tumor indication. See our latest analysis for CARsgen Therapeutics Holdings. The satri-cel approval came after a mixed period for CARsgen Therapeutics Holdings. The 1-day share price return was 7.68%, while the 30-day share price return was down 21.81% and the 1-year...

China Taiping Insurance Holdings (SEHK:966) drew investor attention after shareholders at its AGM on 24 June 2026 approved a final dividend of HK$1.23 per share for the 2025 financial year. See our latest analysis for China Taiping Insurance Holdings. At a share price of HK$18.52, China Taiping Insurance Holdings has seen its 7 day share price return fall 10.88% and its 30 day share price return decline 6.79%, while the 1 year total shareholder return stands at 23.81% and the 3 year total...

Recent commentary on the aluminum extrusion market has highlighted projected growth in Asia Pacific, where United Company RUSAL International (SEHK:486) is a major producer serving construction and infrastructure demand across multiple regional end markets. See our latest analysis for United Company RUSAL International. Despite the supportive backdrop for aluminum extrusion demand, United Company RUSAL International’s share price has been weak. The stock is down 14.6% over 30 days and 35.8%...

Bank of China (SEHK:3988) has completed a RMB50b issuance of 10 year write down tier 2 capital bonds, a step that directly affects its capital structure, regulatory capital ratios, and long term funding mix. See our latest analysis for Bank of China. At a share price of HK$5.09, Bank of China has delivered a 12.36% year to date share price return, while its 1 year total shareholder return of 14.58% and very large 5 year total shareholder return point to momentum that has built steadily over...

Earlier this month, Ping An Healthcare and Technology upgraded its Ping An AI Doctor service, integrating the large‑model-powered tool across core Ping An apps to deliver rapid, AI-led consultations supervised throughout by licensed physicians and connected to an extensive online-to-offline healthcare network. On the same day, the company also announced the resignation of its long-serving CFO and board secretary, with experienced Ping An Group executive Qin Xu stepping in as CFO, joint...

Bright Smart Securities & Commodities Group earnings trigger fresh look at the stock Bright Smart Securities & Commodities Group (SEHK:1428) has just reported full year results to March 31, 2026, with revenue slightly lower year on year but higher net income and earnings per share. See our latest analysis for Bright Smart Securities & Commodities Group. Despite the improved full year profitability, Bright Smart Securities & Commodities Group’s share price has been under pressure, with a 30...

LFG Investment Holdings (SEHK:3938) has just released its FY 2026 numbers, with first half revenue of HK$33.1 million and basic EPS of HK$0.0069. This is set against trailing twelve month revenue of HK$79.7 million and basic EPS of HK$0.018 as the company moved into profit after earlier losses. Over the past few reporting halves, revenue has shifted from HK$7.3 million in 1H FY 2025 to HK$15.6 million in 2H FY 2025 and then to HK$33.1 million in 1H FY 2026. EPS went from a loss of HK$0.0431...

The fact that multiple FIT Hon Teng Limited ( HKG:6088 ) insiders offloaded a considerable amount of shares over the...

EuroEyes International Eye Clinic Limited ( HKG:1846 ) is about to trade ex-dividend in the next three days. The...

Datang Environment Industry Group Co., Ltd. ( HKG:1272 ) is about to trade ex-dividend in the next 3 days. The...

CSPC Pharmaceutical Group (SEHK:1093) has drawn fresh investor attention after two drug developments in China, including approval of a quick dissolving albumin bound paclitaxel and regulatory acceptance of a new hypertension combination tablet. See our latest analysis for CSPC Pharmaceutical Group. Despite these clinical milestones, CSPC Pharmaceutical Group’s recent share price momentum has been weak, with the 30 day share price return down 10.8% and the year to date share price return down...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

It looks like BOE Varitronix Limited ( HKG:710 ) is about to go ex-dividend in the next 3 days. The ex-dividend date is...

AV Concept Holdings (SEHK:595) has reported a punchy set of FY 2026 numbers, with first half revenue of HK$857.2 million and basic EPS of HK$0.0687. This is set against trailing 12 month revenue of HK$1.3 billion and EPS of HK$0.2551, which highlight the scale of its recent earnings profile. The company’s revenue has moved from HK$560.7 million in the second half of FY 2025 to HK$857.2 million in the first half of FY 2026. Over the same period, basic EPS shifted from a loss of HK$0.0029 per...

Emperor International Holdings (SEHK:163) has reported FY 2026 first half revenue of HK$1,569.2 million alongside a basic EPS loss of HK$0.42, keeping the focus firmly on how its income statement is holding up. Over recent periods the company has seen revenue move from HK$559.2 million in 1H FY 2025 to HK$1,001.3 million in 2H FY 2025 and HK$1,569.2 million in 1H FY 2026. Over the same intervals, losses expanded from HK$1,042.3 million to HK$1,278.6 million and then HK$2,290.6 million on a...